Serious Mental Illness During COVID-19:
An Overview for Community Health Providers
Course hours 1.5 CEU Credits 1.5
Oliver Freudenreich, MD, FACLP
Dr. Freudenreich is the Co-Director of the Massachusetts General Hospital (MGH) Schizophrenia Clinical and Research Program and Director of the MGH Fellowship in Public and Community Psychiatry. He is also a deputy editor for the journal Psychosomatics. Dr. Freudenreich has published extensively in his areas of interest and written a handbook on psychotic disorders.
This training will describe specific clinical challenges for clinicians and care providers who manage patients with SMI. It will emphasize challenges that cut across diagnostic categories such as securing resources to address cognitive difficulties, for example ,or securing optimal medical care. The training will put these difficulties in the context of the COVID-19 pandemic, including how the crisis is affecting the workforce and the critical need for workforce protection.
In addition, the course will put the efforts of individual clinicians and mental health providers into the larger context of an overstretched mental healthcare system that the current public health crisis has uncovered, particularly vis-à-vis the range of psychiatric and medical resources needed to optimally help the SMI population.
Course Objectives Include:
1) Psychosis – What it is and also what it is not.
2) Identifying psychiatric and medical conditions that can cause psychosis.
3) Clinical vignettes as examples about how psychosis can present with various conditions.
4) Practical strategies around how to best help somebody who is experiencing psychosis.
3) Understanding the strategies to involve parents in youth substance use treatment